* Chimerix Inc CMRX.OQ reported a quarterly adjusted loss
of 20
cents per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -24
cents. The mean expectation of seven analysts for the quarter
was for a loss of 24 cents per share. Wall Street expected
results to range from -27 cents to -18 cents per share.
* Revenue fell 99.5% to $4.00 thousand from a year ago;
analysts
expected $60.00 thousand.
* Chimerix Inc's reported EPS for the quarter was a loss
of 20
cents.
* The company reported a quarterly loss of $18.16 million.
* Chimerix Inc shares had risen by 28.8% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for Chimerix
Inc is
$7.00
This summary was machine generated from LSEG data February 29 at
02:32 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.24 -0.20 Beat
Sep. 30 2023 -0.23 -0.27 Missed
Jun. 30 2023 -0.24 -0.21 Beat
Mar. 31 2023 -0.25 -0.24 Beat